Connection

James Bearden to Prostate-Specific Antigen

Back to Details
This is a "connection" page, showing publications James Bearden has written about Prostate-Specific Antigen.
James Bearden
Connection Strength
0.066
Prostate-Specific Antigen
  1. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 08 15; 127(16):2954-2965.
    View in: PubMed
    Score: 0.044
  2. Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biol Ther. 2011 Jul 15; 12(2):119-24.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.